Your browser doesn't support javascript.
loading
Progression of pulmonary veno-occlusive disease without pulmonary hypertension.
Beshay, Sarah; Humbert, Marc; Barrios, Roberto; Sahay, Sandeep.
Afiliación
  • Beshay S; Department of Internal Medicine, Division of Pulmonary, Critical Care & Sleep Medicine Houston Methodist Lung Center Houston Texas USA.
  • Humbert M; School of Medicine Université Paris-Saclay Le Kremlin-Bicêtre France.
  • Barrios R; Assistance Publique-Hôpitaux de Paris (AP-HP) Service de Pneumologie et Soins Intensifs Respiratoires, Hôpital Bicêtre Le Kremlin-Bicêtre France.
  • Sahay S; INSERM UMR_S 999 Hôpital Marie Lannelongue Le Plessis-Robinson France.
Pulm Circ ; 12(1): e12046, 2022 Jan.
Article en En | MEDLINE | ID: mdl-35506066
Pulmonary veno-occlusive disease (PVOD) is a progressively fatal disease with no definitive treatment options. PVOD can be a result of genetic mutation but can also be due secondary to exposure to solvents or chemotherapeutic agents. Generally, at the time of diagnosis PVOD is associated with hemodynamically confirmed pulmonary hypertension (PH). In this study, we describe a patient who was diagnosed with PVOD early in the disease without hemodynamically confirmed PH. She had histologically confirmed PVOD. Her clinical presentation posed management challenges and prednisone therapy was used to stabilize her disease. This case and some recently published reports highlight possible immune dysregulation in PVOD and role for immuno-suppressive therapy in these patients.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Pulm Circ Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Pulm Circ Año: 2022 Tipo del documento: Article